/KASE, December 31, 14/ – Chimpharm JSC (Shymkent), whose securities are
officially listed on Kazakhstan Stock Exchange (KASE), has provided KASE with
the following press-release of December 25, 2014:
quote
Annual national teleconference "New industrialization. Results of the first
five- year plan of the state program for accelerated industrial and innovative
development of the Republic of Kazakhstan" with the participation of the Head of
State was broadcasted live from the new ampule and infusion plant of
Chimpharm JSC. President of the Republic of Kazakhstan called Shymkent a
"pharmaceuticals production flagship" noting the contribution of Chimpharm JSC
in the development of the pharmaceutical industry.
unquote
Press-release is available on KASE website in Russian at
http://www.kase.kz/files/emitters/CHFM/chfm_reliz_301214.pdf
[2014-12-31]